{
  "trial_id": "NCT00101829",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Weighs at least 40 kg",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Meets European criteria proposed by the American-European Consensus Group for primary",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Sjogren's syndrome",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Has 1 or more of the following symptoms of Sjogren's syndrome: fatigue; joint pain;",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Agrees to use acceptable methods of contraception during the study and for 12 months after the end of treatment",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Active infection",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Known coronary artery disease, significant cardiac arrhythmias, or severe congestive heart failure (New York Heart Association class III or IV)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current use of anticoagulants",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of viral encephalitis/meningitis and ICH, but no recent symptoms. No known coronary artery disease or severe congestive heart failure.",
  "_meta": {
    "topic_id": "4",
    "trial_id": "NCT00101829",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}